Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06386796 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 10, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Apr 1, 2025 to Oct 1, 2026
    • Study completion date: Jun 6, 2025 to Oct 1, 2026
    v4
  2. Site details revisedv3
  3. Primary completion date: Dec 31, 2025 to Apr 1, 2025
    • Study completion date: Apr 1, 2026 to Jun 6, 2025
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To study the ability of RRI, measured by bedside Doppler ultrasound, in detecting acute kidney injury in high-risk patients admitted to surgical intensive care unit, Aswan university hospital, compared with renal biomarkers and conventional assessment using urine output and serum creatinine levels.
Trial Details
NCT Number NCT06386796
Lead Sponsor Aswan University
Conditions
(from sponsor)		 Acute Kidney Injury, Critical Illness
Related terms Acute Kidney Injury, Critical Illness
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov